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were accessed by DXA. Body mass index (BMI) was also calculated. 
Adequate statistical tests were used (statistical significance p < 0.05).
Results: The mean 25(OH)D after supplementation with vita-
min D was significantly higher :16.2 (± 6.7) vs 26.6 (± 9.1) ng/ml, p 
< 0.05. A significant reduction in the mean total cholesterol [180.3 
(± 20.2) vs 164.6 (± 21.9) mg/dl, p = 0.033) was detected after one 
year of vitamin D supplementation. However, no changes were 
observed in the mean LDL-cholesterol, HDL-cholesterol, triglyc-
erides, glycaemia, HbA1c neither in the means of other anthropo-
metric variables.
Conclusions: In T2DM women treated with antidiabetic oral 
medications and supplementation with vitamin D, a significant in-
crease in the mean total cholesterol was observed and no change in 
the glycemic control or the remaining lipid profile was detected. The 
results of this study are consistent with the data of recent studies, 
which suggest that vitamin D is a possible marker of the general 
health, but not a potential therapy for T2DM.
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Introduction: We have seen no well-defined approach to calcu-
lating vitamin D dose in patients with musculoskeletal system dis-
eases and vitamin D deficiency.
Objectives: To assess the efficacy and safety of individual tar-
geted vitamin D therapy in postmenopausal women with skeletal 
diseases (systemic osteoporosis and osteoarthritis).
Methods: Individual targeted therapy of vitamin D deficiency 
consists of two periods – saturation period and maintenance therapy 
period, during which patients take it constantly. Duration of satura-
tion therapy is calculated by the formula: Saturation therapy dura-
tion (days) = (100 – blood 25(OH)D level (ng/mL)) × body weight 
(kg)/100, The therapy for saturation includes combined calcium 
(1,000 mg of calcium and 800 IU of vitamin D) and 3,000 IU of vita-
min D per day. Maintenance therapy includes 2 000 IU of vitamin D 
per day. The study involved 70 postmenopausal women aged 46-87 
years. All patients were divided into two groups: main. 50 women 
who took individual targeted vitamin D therapy (50 subjects, 65.1 ± 
8.8 years old, BMI 27.22 ± 4.51 kg/m2) and control (20 subjects, 64.5 
± 11.1 years old, BMI 26.68 ± 4.95 kg/m2). The duration of the treat-
ment consists of 3 months starting on the 1st Oct 2013.
Results: In 3 months after the start of the treatment there was a 
significant (p < 0.001) increase in 25(OH)D levels in the treatment 
group: 35.60 ± 8.21 nmol/L as compared to baseline levels of 25.20 ± 
9.76 nmol/l. Remarkably, the treatment was most effective in the oldest 
subgroup (> 70 yrs.), as well as in subjects with the BMI 25-28,99 kg/m2. 
After the treatment, there were no changes in calcium levels.
Conclusions: The suggested individual targeted vitamin D ther-
apy was proven to be effective in postmenopausal women. As the 
treatment turned out to be effective, relatively quick, and had a rea-
sonable safety profile it may be beneficial for all vitamin D deficient 
postmenopausal women.
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Objective: The aim of our study was to evaluate the prevalence of 
hypovitaminosis D and the associations between 25(OH)D and PTH 
serum levels in a sample of individuals representative of the main-
land Portuguese population.
Material and methods: PORMETS is a national cross-sectional 
study of a representative sample of 4095 non-institutionalized 
adults, selected from the primary health care centers lists. 500 par-
ticipants (286 women and 214 men) were randomly selected to be 
included in the present study. A fasting venous blood sample was 
collected and freezing samples were stored at –80º C. Vitamin D ad-
equacy was classified according to IOM criteria. A “blunted PTH re-
sponse” was defined as a PTH within the reference range in the 
presence of a 25OHD < 12 ng/mL.
Results: Mean (standard deviation) 25(OH)D levels were 14.1 
(5.8) ng/mL. According to Vitamin D adequacy categories, deficiency 
was present in 37.7 %, insufficiency in 47.9%, inadequate in 13.8% and 
optimal levels in 0.6% of the participants. PTH and 25(OH)D levels 
were not significantly correlated and a “blunted PTH response” was 
presented in 89.0% of the participant with vitamin D deficiency.
Conclusions: A high prevalence of hypovitaminosis D was ob-
served in this Portuguese population-based study. These results are 
supported by previously published evidence from Portugal, although 
in specific population groups recruited in hospital setting. Attending 
to low levels and inadequate intake of Vitamin D and possible insuf-
ficient solar exposure in the general population it is urgent to devel-
op national policies to increase awareness of the importance of 
Vitamin D for good health and to develop strategies for the diagnosis 
and treatment of hypovitaminosis D, namely in at-risk groups. Food 
fortification may also deserve a broad national debate and lifestyle 
changes, including weight control and outdoor physical activity 
must also be encouraged.
